WO2008142888A1 - アクロレイン、インターロイキン－６及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法 - Google Patents

アクロレイン、インターロイキン－６及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法 Download PDF

Info

Publication number
WO2008142888A1
WO2008142888A1 PCT/JP2008/052701 JP2008052701W WO2008142888A1 WO 2008142888 A1 WO2008142888 A1 WO 2008142888A1 JP 2008052701 W JP2008052701 W JP 2008052701W WO 2008142888 A1 WO2008142888 A1 WO 2008142888A1
Authority
WO
WIPO (PCT)
Prior art keywords
polyamine oxidase
subject
detecting
interleukin
indications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/052701
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Kazuei Igarashi
Shinjyuro Namiki
Madoka Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University NUC
Original Assignee
Chiba University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba University NUC filed Critical Chiba University NUC
Priority to EP08711525A priority Critical patent/EP2163645B1/en
Priority to US12/598,125 priority patent/US20100167322A1/en
Publication of WO2008142888A1 publication Critical patent/WO2008142888A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PCT/JP2008/052701 2007-05-18 2008-02-19 アクロレイン、インターロイキン－６及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法 Ceased WO2008142888A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08711525A EP2163645B1 (en) 2007-05-18 2008-02-19 Method of detecting cerebral stroke or asymptomatic cerebral infarction using acrolein, interleukin-6 and crp contents, polyamine oxidase activity or polyamine oxidase protein content and subject's age as indications
US12/598,125 US20100167322A1 (en) 2007-05-18 2008-02-19 Method of detecting cerebral stroke or asymptomatic cerebral infarction using acrolein, interleukin-6 and crp contents, polyamine oxidase activity or polyamine oxidase protein content and subject's age as indicators

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007132239A JP5339227B2 (ja) 2007-05-18 2007-05-18 アクロレイン、インターロイキン−６及びｃｒｐの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法
JP2007-132239 2007-05-18

Publications (1)

Publication Number Publication Date
WO2008142888A1 true WO2008142888A1 (ja) 2008-11-27

Family

ID=40031607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/052701 Ceased WO2008142888A1 (ja) 2007-05-18 2008-02-19 アクロレイン、インターロイキン－６及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法

Country Status (4)

Country Link
US (1) US20100167322A1 (https=)
EP (1) EP2163645B1 (https=)
JP (1) JP5339227B2 (https=)
WO (1) WO2008142888A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012067150A1 (ja) * 2010-11-16 2012-05-24 三菱化学株式会社 Interleukin-6 receptor subunit beta蛋白質による脳梗塞の検査方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6499342B2 (ja) * 2018-03-19 2019-04-10 隆樹 日和佐 脳梗塞の診断マーカー

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05176932A (ja) * 1991-12-27 1993-07-20 Toa Medical Electronics Co Ltd 脳梗塞の診断方法
JP2002095942A (ja) 2000-09-22 2002-04-02 Yoshiyuki Sawada 気体溶解装置
JP2005522669A (ja) 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
JP2005304476A (ja) 2004-03-25 2005-11-04 Kazue Igarashi ポリアミン、アクロレインの含有量又はポリアミンオキシダーゼ活性又はその蛋白質量を指標とした脳卒中・無症候性脳梗塞の診断方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05176932A (ja) * 1991-12-27 1993-07-20 Toa Medical Electronics Co Ltd 脳梗塞の診断方法
JP2002095942A (ja) 2000-09-22 2002-04-02 Yoshiyuki Sawada 気体溶解装置
JP2005522669A (ja) 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
JP2005304476A (ja) 2004-03-25 2005-11-04 Kazue Igarashi ポリアミン、アクロレインの含有量又はポリアミンオキシダーゼ活性又はその蛋白質量を指標とした脳卒中・無症候性脳梗塞の診断方法

Non-Patent Citations (20)

* Cited by examiner, † Cited by third party
Title
ALARCON, R. A., ANAL. CHEM., vol. 40, 1968, pages 1704 - 1708
BRANES R.W. ET AL.: "Neural networks for ischemic stroke", JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, vol. 15, no. 5, 2006, pages 223 - 227, XP005643527 *
HOSHI T. ET AL.: "Mushokosei Nokosoku to Ensho Hanno no Kanren", THE JOURNAL OF ADULT DISEASES, vol. 35, no. 5, 2005, pages 552 *
IGARASHI ET AL., J. BACTERIOL., vol. 166, 1986, pages 128 - 134
IGARASHI, K. ET AL., AMINO ACIDS, vol. 31, 2006, pages 477 - 483
KATAGIRI D. ET AL.: "Nokosoku Biomarker no Kaihatsu", PRE SYMPTOMATIC MEDICINE AND ANTI AGING, vol. 16, no. 1, 27 April 2007 (2007-04-27), pages 31 - 35 *
NISHIMURA H. ET AL.: "Nosotchu Hassho.Saihatsu no Yobo - Seikatsu Shukan no Kaizen wa Yobo ni Yakudatsuka Seikatsu Shukan to Nosotchu Sonoto no Kiken Inshi tono Sogo Kankei", THE JOURNAL OF ADULT DISEASES, vol. 35, no. 4, 2005, pages 407 - 414 *
OTSUKA T.: "Nosotchu Yogo Yosoku ni Okeru Tobu CT Shoken no Yuyosei ni Tsuite", JAPANESE JOURNAL OF REHABILITATION MEDICINE, vol. 40, no. 7, 2003, pages 443 - 452 *
REBROVA O.Y. ET AL.: "Development and realization of the artificial neural network for diagnostics of stroke type", LECTURE NOTES IN COMPUTER SCIENCE, vol. 3696, 2005, pages 659 - 663, XP019018106 *
RIDKER PM. ET AL., ENGL J MED, vol. 347, 2002, pages 1557 - 1565
SAKATA ET AL., BIOCHEM. BIOPHYS RES. COMMUN., vol. 305, 2003, pages 143 - 149
SAKATA, K. ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 305, 2003, pages 143 - 149
SATO M. ET AL.: "Manseiki Nosotchu Kanja ni Okeru Kokando CRP, Interleukin 6 no Josho", JAPANESE JOURNAL OF STROKE, vol. 26, no. 3, 2004, pages 423 - 429 *
See also references of EP2163645A4 *
SHARMIN ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 282, 2001, pages 228 - 235
SMITH, C. J. ET AL., BMC NEUROL., vol. 15, no. 4, 2004, pages 2
TOMITORI, H. ET AL., STROKE, vol. 36, 2005, pages 2609 - 2613
TZOULAKI, I. ET AL., CIRCULATION., vol. 115, 2006, pages 2119 - 2127
WAKUGAWA, Y. ET AL., STROKE, vol. 37, 2006, pages 27 - 32
YAMAMOTO H. ET AL.: "Shinbo Saido ni Okeru Mushokosei Nokosoku no Kikensei ni Taisuru, Shinkei Taiekisei Inshi ni Kansuru Kento", DAI 58 KAI KOKURITSU BYOIN RYOYOJO SOGO IGAKUKAI KOEN SHOROKUSHU, 6 October 2003 (2003-10-06), pages 396 + ABSTR. NO. P3-H-B12-7 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012067150A1 (ja) * 2010-11-16 2012-05-24 三菱化学株式会社 Interleukin-6 receptor subunit beta蛋白質による脳梗塞の検査方法

Also Published As

Publication number Publication date
US20100167322A1 (en) 2010-07-01
EP2163645A1 (en) 2010-03-17
EP2163645A4 (en) 2010-07-21
EP2163645B1 (en) 2012-09-26
JP2008286651A (ja) 2008-11-27
JP5339227B2 (ja) 2013-11-13

Similar Documents

Publication Publication Date Title
WO2006126008A3 (en) Improved immunoassay methods
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
EP1975623A3 (en) Sample analyzer
WO2008007242A3 (en) Increased specificity of analyte detection by measurement of bound and unbound labels
WO2008008785A3 (en) Ultra-sensitive detection of analytes
BR0015582A (pt) Detecção imunológica de hìbridos de rna:dna em microarrays
EP2386860A3 (en) Predicting mortality and detecting severe disease
EP1957989A4 (en) DEVICE FOR DETECTING THE PRESENCE OR QUANTITY OF AN ANALYTE IN A LIQUID TEST AND METHOD THEREFOR
BRPI0814201A2 (pt) Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador
WO2005080602A3 (en) Immunological detection of rna:dna hybrids on microarrays
WO2006014351A3 (en) Exploring fluorophore microenvironments
EP2266996A3 (en) New labelling strategies for the sensitive detection of analytes
WO2007133586A3 (en) Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
JP2015230280A5 (https=)
EP2520669A3 (en) Mild osteoathritis biomarkers and uses thereof
WO2007059065A3 (en) Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
WO2008122960A3 (en) Label-free optical detection method
WO2005073405A3 (en) Catalytic polynucleotide and its use for determination of analytes
EP1715347A4 (en) PROTEIN MEASURING METHOD
WO2008142888A1 (ja) アクロレイン、インターロイキン－６及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
WO2007094805A3 (en) Method for electrocatalytic protein detection
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN
ATE363069T1 (de) Bestimmung der genauigkeit eines probevolumens in biosensoren
Rasmussen et al. Combined assessment of serum free and total T4 in a general clinical setting seemingly has limited potential in improving diagnostic accuracy of thyroid dysfunction in dogs and cats.

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711525

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008711525

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12598125

Country of ref document: US